Home › Funds › WS MANAGEMENT LLLP › CROX
WS MANAGEMENT LLLP position in CROX
CROCS INC · Consumer Discretionary
WS MANAGEMENT LLLP reported holding 150,000 shares of CROX (CROCS INC) in its Q2 2026 13F filing — a position valued at US$18.1M, representing 2.51% of its reported portfolio and ranking #13 among its reported holdings. WS MANAGEMENT LLLP has disclosed CROX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How WS MANAGEMENT LLLP's CROX position evolved
WS MANAGEMENT LLLP first disclosed a stake in CROX in Q1 2025 at 50,000 shares (US$5.3M). The position peaked in Q2 2026 at 150,000 shares, worth US$18.1M. Across 6 filings, WS MANAGEMENT LLLP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 150,000 shares valued at US$18.1M. Notable position changes include a 198% increase in Q2 2025 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 50.00K | $5.31M | New |
| Q2 2025 | 149.00K | $15.09M | Add |
| Q3 2025 | 129.00K | $10.78M | Reduce |
| Q4 2025 | 129.00K | $11.03M | Hold |
| Q1 2026 | 150.00K | $12.45M | Add |
| Q2 2026 | 150.00K | $18.10M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 30 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$96.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Patient Capital Management, LLC 799.43K sh · $96.44M · Q2 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Evercore Wealth Management, LLC 594.86K sh · $71.76M · Q2 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
More on WS MANAGEMENT LLLP
FAQ
How long has WS MANAGEMENT LLLP held CROX?
WS MANAGEMENT LLLP has disclosed CROX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is WS MANAGEMENT LLLP's current position in CROX?
As of Q2 2026, WS MANAGEMENT LLLP holds 150.00K shares of CROX (CROCS INC), valued at $18.10M, representing 2.51% of its reported portfolio and ranking #13.
Has WS MANAGEMENT LLLP been buying or selling CROX?
In the latest 13F filing (Q2 2026), WS MANAGEMENT LLLP held unchanged its position in CROX. The position peaked in Q2 2026 at 150.00K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.